ライフサイエンスコーパス: recombinant adenovirus

1 ats using short interfering RNA delivered by recombinant adenovirus.

2 y overexpression of superoxide dismutase via recombinant adenovirus.

3 erexpressed in PA myocytes with the use of a recombinant adenovirus.

4 and CYP7A1 were mediated via infection with recombinant adenoviruses.

5 Recombinant adenovirus (10(13) particles per kilogram) o

6 limb ischemia after intravenous injection of recombinant adenoviruses (10(9) plaque-forming units) en

7 luated the ability of an enteric adenovirus, recombinant adenovirus 41 (rAd41), to elicit intestinal

8 n and immune modulation with a DNA prime and recombinant adenovirus 5 (rAd5) boost vaccine.

9 the rBCG-primed monkeys after boosting with recombinant adenovirus 5 (rAd5) expressing the SIV antig

10 ) 505 was a phase 2b efficacy trial of a DNA/recombinant adenovirus 5 (rAd5) HIV vaccine regimen.

11 ta from the HVTN 505 efficacy trial of a DNA/recombinant adenovirus 5 (rAd5) vaccine regimen, we foun

12 We extended and optimized our previous recombinant adenovirus 5 (rAd5)-based vaccine platform c

13 hesized that the efficacy of a DNA prime and recombinant adenovirus 5 boost vaccination regimen (DNA/

14 vaccinia HIV clade B (NYVAC-B) vaccine and a recombinant adenovirus 5-vectored (rAd5-vectored) vaccin

15 We created the recombinant adenoviruses Ad-CMV-GFP-IRES (CGI), Ad-CGI-H

16 is study, we examined whether infection with recombinant adenovirus (Ad) encoding CD154 and/or treatm

17 expressed in lung cancer cell lines through recombinant adenovirus (Ad) infection (Ad-WWOX), and thr

18 Recombinant adenovirus (Ad) is a powerful tool in gene t

19 A recombinant adenovirus (Ad) that expresses ECSOD(R213G)

20 Rh MDDCs were modified by recombinant adenovirus (Ad) transduction and characteriz

21 A recombinant adenovirus (Ad) vector expressing the E2 pro

22 this study, we analyzed interactions between recombinant adenovirus (Ad) vectors and mouse DCs.

23 of 'smart' nanoparticles that are based upon recombinant adenovirus (Ad) vectors and that combine mul

24 he widespread use of replication-incompetent recombinant adenovirus (Ad) vectors as candidate vaccine

25 ma cell lines MDA-MB-468 and SK-BR-3 using a recombinant adenovirus (Ad-IRF-1).

26 To determine the function of Nnat, a recombinant adenovirus (Ad-Nnat) was used to overexpress

27 We then transduced hES2-vCMs with the recombinant adenoviruses (Ad) Ad-PLB or Ad-S16E-PLB to o

28 protein in primary CD4(+) cells by use of a recombinant adenovirus (Ad5/Delta32) was able to down-re

29 To this end, we generated a recombinant adenovirus (AdMYH6) to deliver the full-leng

30 was induced by infection of myocytes with a recombinant adenovirus (AdPak1) containing cDNA for a co

31 Recombinant adenoviruses (Ads) are useful tools in gene

32 catenin/Tcf4 pathway is activated by using a recombinant adenovirus AdTOP-CMV-TK, which carries a her

33 When cells were infected with a recombinant adenovirus (AdV) encoding dominant-negative

34 Recombinant adenovirus (Adv) readily transduces DCs in v

35 arby canine kidney cells, were packaged into recombinant adenovirus and delivered to WIF-B cells in v

36 In chimpanzees successfully vaccinated with recombinant adenovirus and DNA against HCV NS3-5, HCV-sp

37 manipulated by using dominant-negative STAT3 recombinant adenoviruses and a specific inhibitor of MAP

38 ppocampal neurons using nuclear injection or recombinant adenoviruses and examined modulation of ion

39 oned into tetracycline-regulated vectors and recombinant adenoviruses and then studied in colorectal

40 different immunogens--recombinant vaccinia, recombinant adenovirus, and plasmid DNA--on the generati

41 Mice were i.v. infected with a recombinant adenovirus, and within the first 24 h of inf

42 Animals primed by intranasal delivery of recombinant adenoviruses, and boosted by intramuscular i

43 Recombinant adenoviruses are presently being tested clin

44 Replication-defective recombinant adenoviruses are the most widely studied rep

45 ther hand, infection with wild-type GSK3beta recombinant adenovirus-associated virus increased activi

46 production and subsequent administration of recombinant adenovirus-based vaccines to both birds and

47 g with a new technique for labeling axons, a recombinant adenovirus bearing the gene for green fluore

48 Here, we developed recombinant adenoviruses bearing engineered CaMs to faci

49 of mitochondrial superoxide dismutase using recombinant adenovirus blunted lipid peroxidation and at

50 Systemic vaccination with a DNA-prime recombinant adenovirus boost regimen preserved memory CD

51 A prime, protein boost as well as DNA prime, recombinant adenovirus boost regimens expressing these a

52 Rhesus monkeys were immunized with DNA prime-recombinant adenovirus boost vaccines encoding a Gag-Pol

53 ly shown that survival in plasmid DNA-primed/recombinant adenovirus-boosted rhesus monkeys that are c

54 Here, we show that recombinant adenovirus can engineer isolated islets to e

55 r system to generate a replication-deficient recombinant adenovirus capable of simultaneously express

56 A polymerase II and III in cells infected by recombinant adenoviruses carrying ectopic E2E-CAT (chlor

57 tly bound the phosphate moiety, we generated recombinant adenoviruses carrying G6Pase wild type and a

58 Recombinant adenovirus-carrying mPax6 or mPax6Delta286 t

59 ganelle level during viral infection using a recombinant adenovirus coding for a mitochondrial tracer

60 Infection with high titers of recombinant adenovirus containing 1.25 kb of the rat CGR

61 A recombinant adenovirus containing a CIC-specific siRNA (

62 f PC in beta-cell function, we constructed a recombinant adenovirus containing a small interfering RN

63 s were infected with a replication-defective recombinant adenovirus containing an inducible KLF4 and

64 r 4 x 10(9) plaque-forming units of E1a-/E3- recombinant adenovirus containing either a rat beta1 Na,

65 cker diabetic fatty (ZDF) (fa/fa) rats, with recombinant adenovirus containing insig-1 or -2 cDNA.

66 Rats were given recombinant adenovirus containing Mn-SOD (Ad.SOD2) or be

67 Recombinant adenovirus containing rat Raldh1 cDNA was ma

68 were made hyperleptinemic by treatment with recombinant adenovirus containing the leptin cDNA.

69 A similar recombinant adenovirus containing the murine IFN-beta (m

70 slets with a cytomegalovirus promoter-driven recombinant adenovirus containing the Nkx6.1 cDNA (AdCMV

71 Recombinant adenoviruses containing 5-HT1A sense and ant

72 osite termination sequence CT were tested in recombinant adenoviruses containing luciferase reporters

73 s were individually expressed in EC by using recombinant adenoviruses, cultured BL cells adhered excl

74 The intradiabodies were expressed from recombinant adenovirus delivered through subtumoral inje

75 inoculation of BALB/cByJ mice with tcMCMV or recombinant adenoviruses differentially activates T help

76 Injection of a recombinant adenovirus encoding a constitutively active

77 CypD would alter mPTP in vivo, we injected a recombinant adenovirus encoding C203S-CypD or WT CypD in

78 inistration of tumor cells transduced with a recombinant adenovirus encoding CD40L (AdvCD40L).

79 n contrast, transduction of pericytes with a recombinant adenovirus encoding dominant-negative T-cell

80 extracts confirmed that HAECs treated with a recombinant adenovirus encoding E2F-1 failed to associat

81 irect intramyocardial injections of either a recombinant adenovirus encoding for SCF (Ad.SCF, n=9) or

82 Transduction of kidney cells with recombinant adenovirus encoding Foxo1 results in insulin

83 , murine CD11c(+) DCs were transduced with a recombinant adenovirus encoding full-length murine T-bet

84 We used a recombinant adenovirus encoding full-length murine tumor

85 yocardial injection of replication-deficient recombinant adenovirus encoding HGF (n=10) or empty null

86 Murine DC were transduced with a recombinant adenovirus encoding hu gal-1 (gal-1-DC).

87 metabolism in vivo, 1 x 1011 particles of a recombinant adenovirus encoding human EL (AdEL), catalyt

88 fection of two-day-old ksr2(-/-) mice with a recombinant adenovirus encoding human IGF-1.

89 DCs infected with a recombinant adenovirus encoding IL-18 (AdIL18DC) express

90 Infection with a recombinant adenovirus encoding KChAP (Ad/KChAP) increas

91 o myoblasts by quantitative infection with a recombinant adenovirus encoding mouse MyoD.

92 Overexpression of SOCS3 in lung using a recombinant adenovirus encoding murine SOCS3 resulted in

93 Mice received a recombinant adenovirus encoding RelB by intranasal aspir

94 eys through vaccination with plasmid DNA and recombinant adenovirus encoding simian-human immunodefic

95 For functional characterization of Smad4, a recombinant adenovirus encoding Smad4 (Ad-Smad4) was gen

96 ERK1/2 inhibitor PD98059, or infection of a recombinant adenovirus encoding the dominant-negative fo

97 We "painted" recombinant adenovirus encoding the reporter gene Escher

98 Cells transduced with recombinant adenoviruses encoding Bid containing mutatio

99 1 mouse pancreatic islets were infected with recombinant adenoviruses encoding enhanced green fluores

100 oxycycline-repressible replication-defective recombinant adenoviruses encoding individual epitope-tag

101 In the present studies, recombinant adenoviruses encoding secreted (human apolip

102 Recombinant adenovirus-engineered dendritic cells (Ad.DC

103 that overexpression of wild-type Axl, using recombinant adenoviruses, enhances Axl phosphorylation a

104 largely overcome by prior immunization with recombinant adenovirus, especially for adjuvants that ar

105 In APN-null mice, recombinant adenovirus-expressed APN reduced exaggerated

106 ial injury 1 day after systemic injection of recombinant adenovirus expressing (1) VEGF, (2) VEGF-tra

107 However, when treated with recombinant adenovirus expressing 5-lipoxygenase (Ad5LO)

108 A recombinant adenovirus expressing a constitutively activ

109 uced the embryonic chicken heart in ovo with recombinant adenovirus expressing a death (FasL) ligand.

110 Here, we show that vaccination with a recombinant adenovirus expressing a truncated ErbB-2 ant

111 marrow-derived DCs transduced with Ad.Neu, a recombinant adenovirus expressing a truncated neu oncopr

112 We constructed a novel recombinant adenovirus expressing Ad12 E1A (Ad-E1A12) th

113 Cells infected with a recombinant adenovirus expressing constitutively active

114 Using a single intrabursal administration of recombinant adenovirus expressing Cre, we demonstrate th

115 arrow-derived macrophages (BMDMs) by using a recombinant adenovirus expressing dominant-negative Ikap

116 23, transduction of IL-12p40(-/-) DCs with a recombinant adenovirus expressing functional IL-23 resto

117 We produced a recombinant adenovirus expressing GLP-1 (rAd-GLP-1) unde

118 Infection of the hearts with a recombinant adenovirus expressing green fluorescent prot

119 s rapidly expanded following boosting with a recombinant adenovirus expressing HIV-1 Env to gp120-spe

120 ury, we used mouse tail vein injections with recombinant adenovirus expressing HNF-6 complementary DN

121 The investigators constructed a recombinant adenovirus expressing human CD55 (AdCAGCD55)

122 pidemia was corrected by co-infection with a recombinant adenovirus expressing human lipoprotein lipa

123 udy we have transfected rat macrophages with recombinant adenovirus expressing IL-4 (Ad-IL4) and demo

124 Replication-deficient recombinant adenovirus expressing MBP-1 was administered

125 ic potential of MBP-1, replication-deficient recombinant adenovirus expressing MBP-1 was given intrat

126 model, we induced plasma APN levels using a recombinant adenovirus expressing mouse APN (AdAPN) and

127 Recombinant adenovirus expressing NudC (Ad-NudC) was use

128 Microarray analysis of cells infected with a recombinant adenovirus expressing ORF63 showed that tran

129 ly, infection of cultured HepG2 cells with a recombinant adenovirus expressing PGC-1alpha directly ac

130 A recombinant adenovirus expressing PRDM5 caused G2/M arre

131 By infecting pre-fusion osteoclasts using recombinant adenovirus expressing PYK2 and its mutants,

132 rradiated Plasmodium yoelii sporozoites or a recombinant adenovirus expressing the P. yoelii circumsp

133 A recombinant adenovirus expressing the RAP protein induce

134 Immunization of B10.PL mice with a recombinant adenovirus expressing the TCR Vbeta8.2 chain

135 inflammation, were used in conjunction with recombinant adenovirus expressing UGRP1.

136 osteosarcoma cells after their exposure to a recombinant adenovirus expressing wild type BRCA1 (Ad.BR

137 Intravenous administration of a recombinant adenovirus expressing wild-type human ABCC6

138 ells transduced with a replication-deficient recombinant adenovirus expressing Z (rAd-Z) are resistan

139 Using recombinant adenoviruses expressing active Notch1 in sma

140 density lipoprotein (HDL), we have generated recombinant adenoviruses expressing apolipoprotein A-I (

141 Recombinant adenoviruses expressing beta-galactosidase,

142 oping and testing tetracycline-regulated and recombinant adenoviruses expressing dominant negative re

143 dothelial cell networks with C3 exoenzyme or recombinant adenoviruses expressing dominant negative Rh

144 d be induced in the absence of IGF action by recombinant adenoviruses expressing MyoD or myogenin, bu

145 an effect that is rescued by infection with recombinant adenoviruses expressing SOD2 and Catalase1.

146 yes were infected with replication-deficient recombinant adenoviruses expressing the beta-galactosida

147 ia was corrected by coinfection of mice with recombinant adenoviruses expressing the mutant apoA-I an

148 obtained by using C57BL/6 mice infected with recombinant adenoviruses expressing the replicating HBV

149 es 261 and 283 were mutated to alanines, and recombinant adenoviruses expressing these apoE mutants w

150 produce mda-7/IL-24 following infection with recombinant adenoviruses expressing this cytokine secret

151 DCs modified by recombinant adenoviruses expressing tumor-associated ant

152 To initiate our studies, we generated three recombinant adenoviruses expressing wild type, constitut

153 3-null H1299 human lung carcinoma cells with recombinant adenoviruses expressing WT p53, p73 or beta-

154 ells were infected with a dominant-negative, recombinant adenovirus, expressing E-cadherin lacking an

155 ent femoral arterial denudation and received recombinant adenovirus, expressing either murine endosta

156 A recombinant adenovirus-expressing hCD59 was generated, a

157 A recombinant adenovirus-expressing Mtb39 (adenoMtb39) was

158 The authors constructed a recombinant adenovirus-expressing murine complement comp

159 rate cohorts also received i.v. injection of recombinant adenovirus-expressing murine GM-CSF (AdGMCSF

160 ransfection, and fibroblasts infected with a recombinant adenovirus-expressing UL142, were used to sc

161 d inside cells using a replication-deficient recombinant adenovirus expression system inhibited LCMV

162 transduction with the replication-deficient recombinant adenovirus expression system to Z and L effe

163 review recent studies combining the tools of recombinant adenovirus for gene delivery, the developmen

164 oses of gag protein, HIV gag plasmid DNA, or recombinant adenovirus-gag.

165 (rAd-IFNalpha/Syn3), a replication-deficient recombinant adenovirus gene transfer vector, for patient

166 se important properties of Vpr, we created a recombinant adenovirus H5.010CMV-vpr (adCMV-vpr) as a to

167 Recombinant adenoviruses have been used as vehicles for

168 In cells infected with either the recombinant adenovirus-HBV or baculovirus-WHV, the repli

169 rials for cystic fibrosis lung disease using recombinant adenovirus in the early 1990s, the field has

170 as precursors to DCs and also for the use of recombinant adenovirus in vaccines or gene therapy.

171 ular microarrays on a micropillar chip using recombinant adenoviruses in a complementary microwell ch

172 in liver by transducing their expression via recombinant adenoviruses in Agpat2(-/-) mice.

173 Using recombinant adenoviruses in conjunction with surgical an

174 Here we show that WT TAg expressed from recombinant adenoviruses in U2OS cells induced the phosp

175 an, and restoring iPLA(2)betaexpression with recombinant adenovirus increases apoptosis toward WT lev

176 transduced ex vivo by BMP cDNA delivered by recombinant adenoviruses induce bone formation and conve

177 Using recombinant adenovirus-infected ER-negative MDA-MB-231 c

178 ength and truncated forms of the enzyme from recombinant adenovirus-infected human 293 cells.

179 transgenic mice (transthyretin HNF-3beta) or recombinant adenovirus infection (AdHNF3beta), and obser

180 previous studies we used transgenic mice or recombinant adenovirus infection to increase hepatic exp

181 We assessed the efficacy and safety of recombinant adenovirus interferon alfa with Syn3 (rAd-IF

182 Overexpression of LAT1 in T24 cells using recombinant adenoviruses led to increased uptake of L-CS

183 We now report that recombinant adenovirus mediated overexpression of the fe

184 and apoptosis in human lung cancer cells by recombinant adenovirus-mediated gene transfer in vitro a

185 In the present study, we transduced recombinant adenovirus-mediated HIF-1alpha in embryonic

186 rogen-independent prostate cancer cells upon recombinant adenovirus-mediated introduction of MBP-1.

187 infection, suggesting that L1 expressed from recombinant adenoviruses might provide protective immuni

188 erexpression of DGAT1 mRNA by >20-fold via a recombinant adenovirus only resulted in approximately 2-

189 e antiviral signals following infection with recombinant adenovirus or by direct nucleic acid transfe

190 Recombinant adenoviruses or baculoviruses expressing rep

191 demonstrated that intratumoral injections of recombinant adenovirus overexpressing p27Kip1 (Adp27) re

192 Administration of a recombinant adenovirus overexpressing SLPI (Adv/SLPI) in

193 Here we show that a recombinant adenovirus-poxvirus prime-boost immunization

194 , followed by two mucosal boosts with either recombinant adenovirus (rAd) or fowlpox virus (rFWPV) ex

195 dminister AERAS-402, a replication-defective recombinant adenovirus (rAd) type 35 expressing Mycobact

196 Although replication-incompetent recombinant adenovirus (rAd) type 5 is a potent vaccine

197 t contribute to the potent immunogenicity of recombinant adenovirus (rAd) vaccine vectors remain larg

198 e that single intranasal immunization with a recombinant adenovirus (rAd) vector encoding both HA of

199 Intramuscular immunization with recombinant adenovirus (rAd) vector-based vaccines expre

200 Recombinant adenovirus (rAd) vectors are being investiga

201 While replication-competent recombinant adenovirus (rAd) vectors can stimulate adeno

202 an populations has led to the development of recombinant adenovirus (rAd) vectors derived from rare A

203 Recombinant adenovirus (rAd) vectors have been shown to

204 at intramuscular injection of nonreplicating recombinant adenovirus (rAd) vectors into rhesus monkeys

205 Rare serotype and chimeric recombinant adenovirus (rAd) vectors that evade anti-Ad5

206 modified for optimal antigen expression and recombinant adenovirus (rAd) vectors, all encoding the g

207 tilizing intramuscularly (i.m.) administered recombinant adenovirus (rAd)-based vectors can induce po

208 vaccines suggest that replication-competent recombinant adenoviruses (rAds) could serve as effective

209 Using recombinant adenovirus (rAdV) as a model for murine APC

210 Biodistribution of recombinant adenovirus (rADV) vectors administered intra

211 Recombinant adenovirus (rAV)-driven c-met overexpression

212 Recombinant adenoviruses replicate only in cancer cells

213 ertk to cultured RCS RPE cells by means of a recombinant adenovirus restored the cells to complete ph

214 ion of primary oligodendrocyte cultures with recombinant adenovirus revealed that expression of Fyn o

215 that therapeutic vaccination with Ad26/MVA (recombinant adenovirus serotype 26 (Ad26) prime, modifie

216 CD8(+) T lymphocyte responses elicited by a recombinant adenovirus serotype 26 (rAd26) vector expres

217 of recombinant adenovirus serotype 5 (rAd5), recombinant adenovirus serotype 28 (rAd28), and recombin

218 In this study, we define a small, recombinant adenovirus serotype 3-derived protein, terme

219 ombinant adenovirus serotype 28 (rAd28), and recombinant adenovirus serotype 35 (rAd35) in associatio

220 tective efficacy of replication-incompetent, recombinant adenovirus serotype 35 (rAd35) vectors expre

221 Intravenous (i.v.) delivery of recombinant adenovirus serotype 5 (Ad5) vectors for gene

222 The Step study of a recombinant adenovirus serotype 5 (Ad5)-based human immu

223 ly increases the immunogenicity of DNA prime-recombinant adenovirus serotype 5 (rAd5) boost and DNA p

224 eutralizing antibodies elicited by DNA prime-recombinant adenovirus serotype 5 (rAd5) boost vaccinati

225 g HIV-1-infected participants who received a recombinant adenovirus serotype 5 (rAd5) HIV-1 gag vacci

226 ccine efficacy trial testing DNA followed by recombinant adenovirus serotype 5 (rAd5) in circumcised,

227 Use of first-generation recombinant adenovirus serotype 5 (rAd5) platforms faile

228 l activation during the first 2 months after recombinant adenovirus serotype 5 (rAd5) prime or boost

229 Recombinant adenovirus serotype 5 (rAd5) vaccine vectors

230 lication deficient and requires the parental recombinant adenovirus serotype 5 (rAd5) vector for repl

231 nd immunogenicity of a replication-defective recombinant adenovirus serotype 5 (rAd5) vector HIV-1 ca

232 A recombinant adenovirus serotype 5 (rAd5) vector-based va

233 Recombinant adenovirus serotype 5 (rAd5) vector-based va

234 The utility of recombinant adenovirus serotype 5 (rAd5) vector-based va

235 infectivity and cell stimulatory capacity of recombinant adenovirus serotype 5 (rAd5), recombinant ad

236 ysis of the phase 2b Step study evaluating a recombinant adenovirus serotype 5 (rAd5)-based HIV-1 vac

237 yellow fever vaccine virus 17D (rYF17D), and recombinant adenovirus serotype 5 (rAd5).

238 he monkeys were boosted a second time with a recombinant Adenovirus serotype 5 vector containing matc

239 othesis in a relevant primate model, we used recombinant adenovirus serotype 5 vectors expressing SIV

240 When apoM(Q22A) was expressed in vivo, using recombinant adenoviruses, smaller plasma HDL particles a

241 Similarly, treatment of 832/13 cells with a recombinant adenovirus specific to FAS (Ad-siFAS) reduce

242 Boosting with recombinant adenovirus strikingly enhances CD8+, but not

243 cells were pulsed with CFP10 expressed in a recombinant adenovirus, surface adsorbed to microspheres

244 ast carcinoma cell line MDA-MB-468 using the recombinant adenovirus, TGF-beta signaling was restored

245 as rAd-IFNa/Syn3) is a replication-deficient recombinant adenovirus that delivers human interferon al

246 To test this hypothesis we used a recombinant adenovirus that expresses a human CFTR cDNA

247 We constructed a recombinant adenovirus that expresses ECSOD(R213G).

248 cells fromnormal human breast tissue using a recombinant adenovirus that expresses green fluorescence

249 This article describes a method for making recombinant adenoviruses that efficiently drive expressi

250 T cells that are most efficiently primed by recombinant adenoviruses that encode EBNA1.

251 n-specific T(CD8(+)) after immunization with recombinant adenoviruses that express antigen driven by

252 Using recombinant adenoviruses that express the preproinsulin

253 Using a recombinant adenovirus to deliver Ag, we demonstrated th

254 ng neonatal rat cardiomyocytes infected with recombinant adenovirus to overexpress tropomodulin.

255 row-derived dendritic cells engineered using recombinant adenovirus to secrete high levels of IL-12p7

256 and granzyme B cleavage sites, and utilized recombinant adenoviruses to express this protein in hepa

257 ide-binding domains (NBD) of G5 and G8 using recombinant adenoviruses to reconstitute biliary sterol

258 accine constructs: (i) replication-defective recombinant adenovirus type 5 (Ad5) expressing human imm

259 We generated recombinant adenovirus type 5 (Ad5) fiber knob, incorpor

260 An HIV-1 DNA prime vaccine, with a recombinant adenovirus type 5 (rAd5) boost, failed to pr

261 1 Env and Gag-Pol by DNA priming followed by recombinant adenovirus type 5 (rAd5) boosting elicited C

262 me-boost immunization regimens revealed that recombinant adenovirus type 5 (rAd5) prime followed by r

263 f a T-cell-based AIDS vaccine delivered with recombinant adenovirus type 5 (rAd5) vectors showed no e

264 iciency virus (SIV) vaccine trial (DNA prime/recombinant adenovirus type 5 [rAd5] boost) (VRC-10-332)

265 We tested the efficacy of a DNA prime-recombinant adenovirus type 5 boost (DNA/rAd5) vaccine r

266 s were vaccinated via three DNA primes and a recombinant adenovirus type 5 boost (weeks 0, 4, 8, and

267 ium cell line (ARPE-19) were transduced with recombinant adenovirus type 5 carrying mouse Elovl4 and

268 ies such dynamics, using a newly constructed recombinant adenovirus type-5 (Ad5) that expresses enhan

269 Boosting with recombinant Adenovirus type-5 (rAd5) vectors resulted in

270 This study assesses the hypothesis that a recombinant adenovirus vaccine based on the nonhuman pri

271 ter vaccines than r30 with an adjuvant and a recombinant adenovirus vaccine expressing r30.

272 An oral recombinant adenovirus vaccine to influenza was well tol

273 osal challenge following immunization with a recombinant adenovirus vaccine vector.

274 on was obtained in COS-1 cells infected with recombinant adenovirus vector (rAdSERCA).

275 with dendritic cells expressing mEGP from a recombinant adenovirus vector exhibited a muted anti-ade

276 Single-dose vaccination with a recombinant adenovirus vector expressing hepacivirus non

277 tic levels of HNF-6 either by infection with recombinant adenovirus vector expressing HNF-6 cDNA by g

278 tegy to bypass this escape mechanism using a recombinant adenovirus vector expressing interleukin-12

279 in vivo priming with a replication-defective recombinant adenovirus vector expressing the lymphocytic

280 f ZTA in cell cycle arrest, we constructed a recombinant adenovirus vector expressing ZTA (Ad-ZTA), w

281 In this study, we report the use of a recombinant adenovirus vector to induce regulatory respo

282 tion based on a beta-galactosidase (betagal)-recombinant adenovirus vector.

283 either naive or had been vaccinated using a recombinant, adenovirus-vectored vaccine 2 weeks before

284 ally, we demonstrated that immunization with recombinant adenovirus vectors expressing NP and M2 sign

285 PLA2s were expressed in MC-/- or MC+/+ using recombinant adenovirus vectors.

286 protection conferred by a highly protective recombinant adenovirus virus serotype 5 (rAd5) encoding

287 multiclade (A, B, and C) envelope (Env) DNA/recombinant adenovirus virus type 5 (rAd5) vaccine studi

288 Based on the results, a recombinant adenovirus was constructed with the expressi

289 AdhMGP recombinant adenovirus was generated by bacterial transp

290 A recombinant adenovirus was generated with the human rho1

291 get the apoptosis of the OFT cardiomyocytes, recombinant adenovirus was used to express the X-linked

292 Recombinant adenovirus was used to increase HSkMC PGC-1a

293 Using these recombinant adenoviruses, we determined that overexpress

294 Several shRNAs expressed from recombinant adenovirus were developed.

295 Recombinant adenoviruses were generated to express repor

296 Four avian smooth muscle MBS-recombinant adenoviruses were prepared and transfected i

297 Mucosally or parenterally administered recombinant adenoviruses were used in prime-boost regime

298 Here, recombinant adenoviruses were used to express each prote

299 Recombinant adenoviruses were used to overexpress green

300 An intertypic recombinant adenovirus with a serotype 3-like hexon gene